Patents by Inventor Shun JIAN

Shun JIAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240094875
    Abstract: The present disclosure discloses a video interaction method and apparatus, an electronic device, and a storage medium. The video interaction method comprises: in response to a recommended video of a target object being played to a first time node, displaying an interactive window at a preset position on a video playback page and continuing playing the recommended video; receiving an object determination operation acting in the interactive window; displaying first object information of an object to be collected in the interactive window, wherein the object to be collected is related to the target object; receiving a collection operation for the object to be collected; and displaying a target page for a user to collect the object to be collected.
    Type: Application
    Filed: November 30, 2023
    Publication date: March 21, 2024
    Inventors: Jingtong JIAN, Jiayi SHI, Yuchen WANG, Licong SONG, Yirui CAO, Qing SONG, Liyue JI, Shun LIU
  • Publication number: 20220143125
    Abstract: The present invention discloses Fuke Qianjin Capsules and a quality control method therefor. The capsules are made of Radix Et Caulis Flemingiae, Caulis Mahoniae, Herba Andrographis, Zanthoxylum dissitum Hemsl., Caulis Spatholobi, Radix Angelicae Sinensis, Radix Codonopsis, and Radix Rosa Laevigata as raw materials. Each of the Fuke Qianjin Capsules contains not less than 2.0 mg of Z-ligustilide, and a total amount of andrographolide and dehydroandrographolide is not less than 1.9 mg. A new standard for controlling quality of the Fuke Qianjin Capsules has been established through an analysis of chemical ingredients in the Fuke Qianjin Capsules. This standard adds a variety of core ingredient content to the existing pharmacopoeia standards. According to the Fuke Qianjin Capsules made in this range, the consistency of effects between different batches is more stable. Moreover, the more the types of core ingredients are limited, the more stable the consistency of the drug effect.
    Type: Application
    Filed: January 14, 2020
    Publication date: May 12, 2022
    Applicant: QIANJIN PHARMACEUTICAL CO., LTD.
    Inventors: Shun JIAN, Yun GONG, Peng ZHANG, Fujun LI, Yonggen LING, Juanjuan HE, Kanghua WANG, Xiuwei YANG